A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis

A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis

Tuberculosis (TB) is an infectious, airborne disease caused by the bacterium Mycobacterium tuberculosis that mainly affects the lungs. Fortunately, tuberculosis is a curable disease, and in recent years, death rates for this disease have decreased. However, the existence of antibiotic-resistant stra...

Full description

Bibliographic Details
Main Authors: Patricia B. da Silva, Eduardo Sinésio de Freitas, Mariana Cristina Solcia, Paula Carolina de Souza, Monize Martins da Silva, Alzir Azevedo Batista, Carlos E. Eismann, Ana Marta C. M. Rolisola, Amauri A. Menegário, Rosilene Fressatti Cardoso, Marlus Chorilli, Fernando R. Pavan
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-12-01
Series:Frontiers in Microbiology
Subjects:
ruthenium(II) complexes
tuberculosis
nanotechnology
oral bioavailability
ICP-MS
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.02930/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2018.02930/full

Similar Items